Transcranial sonography in depression

International Review of Neurobiology

Volumn 90, Issue C, 2010, Pages 259-272

  Mijajlovic, Milija D ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Depression in Neurodegenerative Diseases; Differential Diagnosis; Transcranial sonography; Unipolar Depression

Indexed keywords

ANTIDEPRESSANT AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; AUTOPSY; BRAIN STEM; DEGENERATIVE DISEASE; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; HUMAN; HUNTINGTON CHOREA; IMAGE ANALYSIS; LIMBIC SYSTEM; MAJOR DEPRESSION; MEDIAN RAPHE NUCLEUS; MESENCEPHALON; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL DETECTION; WILSON DISEASE;

EID: 77955406433     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(10)90018-4     Document Type: Chapter

References (44)

1. Arango V., Underwood M.D., Boldrini M., Tamir H., Kassir S.A., Hsiung S., et al. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 2001, 25:892-903.
2. Baumann B., Bielau H., Krell D., Agelink M.W., Diekmann S., Wurthmann C., et al. Circumscribed numerical deficit of dorsal raphe neurons in mood disorders. Psychol. Med. 2002, 32:93-103.
3. Becker G., Struck M., Bogdahn U., Becker T. Echogenicity of the brainstem raphe in patients with major depression. Psychiatry Res. 1994, 55:75-84.
4. Becker G., Becker T., Struck M., Lindner A., Burzer K., Retz W., et al. Reduced echogenicity of brainstem raphe specific to unipolar depression: A transcranial color-coded real-time sonography study. Biol. Psychiatry 1995, 38:180-184.
5. Becker T., Becker G., Seufert J., Hofmann E., Lange K.W., Naumann M., et al. Parkinson's disease and depression: Evidence for an alteration of the basal limbic system detected by transcranial sonography. J. Neurol. Neurosurg. Psychiatry 1997, 63:590-596.
6. Becker T., Becker D., Berg D., et al. Pathological findings in neuropsychiatric diseases. Echoenhancers and Transcranial Color Duplex Sonography 1998, 359-373. Blackwell Science, London. U. Bogdahn, G. Becker, F. Schlacketzki (Eds.).
7. Becker G., Berg D., Lesch K.P., Becker T. Basal limbic system alteration in major depression: A hypothesis supported by transcranial sonography and MRI findings. Int. J. Neuropsychopharmacol. 2001, 4:21-31.
8. Berg D., Supprian T., Hofmann E., Zeiler B., Jager A., Lange K.W., et al. Depression in Parkinson's disease: Brainstem midline alteration on transcranial sonography and magnetic resonance imaging. J. Neurol. 1999, 246:1186-1193.
9. Berg D., Supprian T., Thomae J., Warmuth-Metz M., Horowski A., Zeiler B., et al. Lesion pattern in patients with multiple sclerosis and depression. Mult. Scler. 2000, 6:156-162.
10. Berg D., Mäurer M., Warmuth-Metz M., Rieckmann P., Becker G. The correlation between ventricular diameter measured by transcranial sonography and clinical disability and cognitive dysfunction in patients with multiple sclerosis. Arch. Neurol. 2000, 57:1289-1292.
11. Berg D., Behnke S., Walter U. Application of transcranial sonography in extrapyramidal disorders: Updated recommendations. Ultraschall. Med. 2006, 27:12-19.
12. Berg D., Godau J., Walter U. Transcranial sonography in movement disorders. Lancet Neurol. 2008, 7:1044-1055.
13. Brooks D.J., Doder M. Depression in Parkinson's disease. Curr. Opin. Neurol. 2001, 14:465-470.
14. Budisic M., Karlovic D., Trkanjec Z., Lovrencic-Huzjan A., Vukovic V., Bosnjak J., et al. Brainstem raphe lesion in patients with major depressive disorder and in patients with suicidal ideation recorded on transcranial sonography. Eur. Arch. Psychiatry Clin. Neurosci. 2009, 10.1007/s00406-009-0043.
15. Carpenter M.B., Sutin J. Human Neuroantomy 1993, Williams and Wilkins, Baltimore.
16. Crossman A.R. Brain stem. In. Gray's Anatomy: The Anatomical Basis of Clinical Practice 2005, 327-351. Churchill Livingston, Edinburgh. S. Standring (Ed.).
17. Cummings J.L. Depression and Parkinson's disease: A review. Am. J. Psychiatry 1992, 149:443-454.
18. Eggers B., Hermann W., Barthel H., Sabri O., Wagner A., Hesse S. The degree of depression in Hamilton rating scale is correlated with the density of presynaptic serotonin transporters in 23 patients with Wilson's disease. J. Neurol. 2003, 250:576-580.
19. Gaenslen A., Unmuth B., Godau J., Liepelt I., Di Santo A., Schweitzer K.J., et al. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: A prospective blinded study. Lancet Neurol. 2008, 7:417-424.
20. Hoeppner J., Prudente-Morrissey L., Herpertz S.C., Benecke R., Walter U. Substantia nigra hyperechogenicity in depressive subjects relates to motor asymmetry and impaired word fluency. Eur. Arch. Psychiatry Clin. Neurosci. 2009, 259:92-97.
21. Unified Huntingtons disease rating scale: Reliability and consistency. Mov. Disord. 1996, 11:136-142. Huntington Study Group.
22. Leentjens A.F., Van den Akker M., Metsemakers J.F., Lousberg R., Verhey F.R. Higher incidence of depression preceding the onset of Parkinson's disease: A register study. Mov. Disord. 2003, 18:414-418.
23. Lieberman A. Depression in Parkinson's disease-a review. Acta Neurol. Scand. 2006, 113:1-8.
24. Meltzer C., Price C., Mathis A., Butters A., Ziolko K., Moses-Kolko E., et al. Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology 2004, 29:2258-2265.
25. Minden S.L., Schiffer R.B. Affective disorders in multiple sclerosis. Review and recommendations for clinical research. Arch. Neurol. 1990, 47:98-104.
26. Naumann M., Becker G., Toyka K.V., Naumann M., Becker G., Toyka K.V., Supprian T., Reiners K. Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography. Neurology 1996, 47:1284-1290.
27. Nieuwenhuys R., Voogd J., Van Huijzen C. The Human Central Nervous System 2008, Springer, Berlin, pp. 889-916.
28. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann. Neurol. 1983, 13:226-231.
29. Postert T., Lack B., Kuhn W., Jergas M., Andrich J., Braun B., et al. Basal ganglia alterations and brain atrophy in Huntington's disease depicted by transcranial real time sonography. J. Neurol. Neurosurg. Psychiatry 1999, 67:457-462.
30. Sabatini U., et al. Involvement of the limbic system in multiple sclerosis patients with depressive disorders. Biol. Psychiatry 1996, 39:970-975.
31. Schuurman A.G., van den Akker M., Ensinck K.T., Metsemakers J.F., Knottnerus J.A., Leentjens A.F., et al. Increased risk of Parkinson's disease after depression: A retrospective cohort study. Neurology 2002, 58:1501-1504.
32. Seniow J., Bak T., Gajda J., Poniatowska R., Czlonkowska A. Cognitive functioning in neurologically symptomatic and asymptomatic forms of Wilson's disease. Mov. Disord. 2002, 17:1077-1083.
33. Seniow J., Mroziak B., Czlonkowska A., Jedryka-Goral A. Self-rated emotional functioning of patients with neurological or asymptomatic form of Wilson's disease. Clin. Neuropsychol. 2003, 17:367-373.
34. Steele J.D., Bastin M.E., Wardlaw J.M., Ebmeier K.P. Possible structural abnormality of the brainstem in unipolar depressive illness: A transcranial ultrasound and diffusion tensor magnetic resonance imaging study. J. Neurol. Neurosurg. Psychiatry 2005, 76:1510-1515.
35. Supprian T., Reiche W., Schmitz B., Grunwald I., Backens M., Hofmann E., et al. MRI ofthe brainstem in patients with major depression, bipolar affective disorder and normal controls. Psychiatry Res. 2004, 131:269-276.
36. Walter U., Krolikowski K., Tarnacka B., Benecke R., Czlonkowska A., Dressler D. Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease. Neurology 2005, 64:1726-1732.
37. Walter U., Dressler D., Wolters A., Wittstock M., Benecke R. Overactive bladder in Parkinson's disease: Alteration of brainstem raphe detected by transcranial sonography. Eur. J. Neurol. 2006, 13:1291-1297.
38. Walter U., Behnke S., Eyding J., Niehaus L., Postert T., Seidel G., et al. Transcranial brain parenchyma sonography in movement disorders: State of the art. Ultrasound Med. Biol. 2007, 33:15-25.
39. Walter U., Hoeppner J., Prudente-Morrissey L., Horowski S., Herpertz S.C., Benecke R. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders. Brain 2007, 130:1799-1807.
40. Walter U., Prudente-Morrissey L., Herpertz S.C., Benecke R., Hoeppner J. Relationship of brainstem raphe echogenicity and clinical findings in depressive states. Psychiatry Res. 2007, 155:67-73.
41. Walter U., Horowski S., Benecke R., Zettl U. Transcranial brain sonography findings related to neuropsychological impairment in multiple sclerosis. J. Neurol. 2007, 254(Suppl. 2):49-52.
42. Walter U., Dressler D., Wolters A., Wittstock M., Benecke R. Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease. Mov. Disord. 2007, 22:48-54.
43. Walter U., Kanowski M., Kaufmann J., Grossmann A., Benecke R., Niehaus L. Contemporary ultrasound systems allow high-resolution transcranial imaging of small echogenic deep intracranial structures similarly as MRI: A phantom study. Neuroimage 2008, 40:551-558.
44. Walter U., Skoloudík D., Berg D. Transcranial sonography findings related to non-motor features of Parkinson's disease. J. Neurol. Sci. 2010, 289(1-2):123-127.